
The Next Generation Immunotherapies: From Innovative Approaches to Overcoming Resistance and Beyond is the European Association for Cancer Research’s (EACR) inaugural virtual conference on this topic, scheduled for February 24–25, 2026.
The two-day virtual summit is dedicated to showcasing cutting-edge developments in immunotherapy, spanning from basic research to clinical applications, with a strong emphasis on addressing resistance – a common challenge in current cancer treatment.
The program will feature invited talks from leading scientists on innovative therapeutic strategies, including novel NK, T, and myeloid cell therapies, mRNA therapies, cytokine targeting, and new combinatorial immune checkpoint blockade strategies.